1. Home
  2. SION vs AHH Comparison

SION vs AHH Comparison

Compare SION & AHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SION
  • AHH
  • Stock Information
  • Founded
  • SION 2019
  • AHH 1979
  • Country
  • SION United States
  • AHH United States
  • Employees
  • SION N/A
  • AHH N/A
  • Industry
  • SION
  • AHH Real Estate
  • Sector
  • SION
  • AHH Finance
  • Exchange
  • SION NYSE
  • AHH Nasdaq
  • Market Cap
  • SION 564.4M
  • AHH 586.7M
  • IPO Year
  • SION 2025
  • AHH 2013
  • Fundamental
  • Price
  • SION $13.69
  • AHH $6.96
  • Analyst Decision
  • SION Strong Buy
  • AHH Buy
  • Analyst Count
  • SION 1
  • AHH 3
  • Target Price
  • SION $32.00
  • AHH $9.83
  • AVG Volume (30 Days)
  • SION 143.7K
  • AHH 917.0K
  • Earning Date
  • SION 05-12-2025
  • AHH 05-07-2025
  • Dividend Yield
  • SION N/A
  • AHH 10.85%
  • EPS Growth
  • SION N/A
  • AHH 9.49
  • EPS
  • SION N/A
  • AHH 0.10
  • Revenue
  • SION N/A
  • AHH $627,963,000.00
  • Revenue This Year
  • SION N/A
  • AHH N/A
  • Revenue Next Year
  • SION N/A
  • AHH $2.00
  • P/E Ratio
  • SION N/A
  • AHH $72.14
  • Revenue Growth
  • SION N/A
  • AHH N/A
  • 52 Week Low
  • SION $7.26
  • AHH $6.10
  • 52 Week High
  • SION $25.19
  • AHH $12.46
  • Technical
  • Relative Strength Index (RSI)
  • SION N/A
  • AHH 46.28
  • Support Level
  • SION N/A
  • AHH $6.74
  • Resistance Level
  • SION N/A
  • AHH $7.20
  • Average True Range (ATR)
  • SION 0.00
  • AHH 0.20
  • MACD
  • SION 0.00
  • AHH -0.00
  • Stochastic Oscillator
  • SION 0.00
  • AHH 31.16

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

About AHH Armada Hoffler Properties Inc.

Armada Hoffler Properties Inc is a real estate company. It engages in developing, building, owning and managing the high-quality, institutional-grade office, retail, and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. It lease its properties under operating leases and recognize base rents. It also recognize revenue from tenant recoveries, through which tenants reimburses the company for expenses paid by them such as utilities, janitorial, repairs and maintenance. The company's operating segment includes office real estate, retail real estate, multifamily residential real estate, and general contracting, real estate financing and real estate services. It generates maximum revenue from the retail real estate segment.

Share on Social Networks: